Skip to content
Disclosery

EXANE DERIVATIVES: ISRG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on ISRG, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 210 ISRG shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 210 shares
    Change vs previous 13F -218 shares

    0.02% of the 13F portfolio, value $42,140.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 428 shares
    Change vs previous 13F -8 shares

    0.04% of the 13F portfolio, value $129,111.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 436 shares
    Change vs previous 13F +179 shares

    0.04% of the 13F portfolio, value $156,649.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 257 shares
    Change vs previous 13F -9 shares

    0.06% of the 13F portfolio, value $255,487.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 266 shares
    Change vs previous 13F -62 shares

    0.06% of the 13F portfolio, value $254,357.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 328 shares
    Change vs previous 13F -254 shares

    0.07% of the 13F portfolio, value $242,362.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 582 shares
    Change vs previous 13F -83 shares

    0.14% of the 13F portfolio, value $476,112.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 665 shares
    Change vs previous 13F not available

    0.15% of the 13F portfolio, value $471,818.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).